Rathkopf, D., Patel, M. R., Choudhury, A. D., Rasco, D., Lakhani, N. J., Hawley, J., … Armstrong, A. J. (2024). 1597MO Clinical activity of BMS-986365 (CC-94676), a dual androgen receptor (AR) ligand-directed degrader and antagonist, in heavily pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). In Annals of Oncology (Vol. 35, pp. S962–S963). Elsevier BV. https://doi.org/10.1016/j.annonc.2024.08.1678

Rathkopf, D., M. R. Patel, A. D. Choudhury, D. Rasco, N. J. Lakhani, J. Hawley, S. Srinivas, et al. “1597MO Clinical activity of BMS-986365 (CC-94676), a dual androgen receptor (AR) ligand-directed degrader and antagonist, in heavily pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).” In Annals of Oncology, 35:S962–63. Elsevier BV, 2024. https://doi.org/10.1016/j.annonc.2024.08.1678.

Rathkopf D, Patel MR, Choudhury AD, Rasco D, Lakhani NJ, Hawley J, et al. 1597MO Clinical activity of BMS-986365 (CC-94676), a dual androgen receptor (AR) ligand-directed degrader and antagonist, in heavily pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). In: Annals of Oncology. Elsevier BV; 2024. p. S962–3.

Rathkopf, D., et al. “1597MO Clinical activity of BMS-986365 (CC-94676), a dual androgen receptor (AR) ligand-directed degrader and antagonist, in heavily pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).” Annals of Oncology, vol. 35, Elsevier BV, 2024, pp. S962–63. Crossref, doi:10.1016/j.annonc.2024.08.1678.

Rathkopf D, Patel MR, Choudhury AD, Rasco D, Lakhani NJ, Hawley J, Srinivas S, Aparicio A, Narayan V, Runcie K, Emamekhoo H, Reichert Z, Nguyen H, Wells A, Kandimalla R, Suryawanshi S, Wu J, Arora V, Pourdehnad M, Armstrong AJ. 1597MO Clinical activity of BMS-986365 (CC-94676), a dual androgen receptor (AR) ligand-directed degrader and antagonist, in heavily pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). Annals of Oncology. Elsevier BV; 2024. p. S962–S963.